Disclosures for "Ischemic Optic Neuropathy With Semaglutide: Global Observational Analysis of Sex- and Formulation-specific Risk"
-
Mr. Lakhani has nothing to disclose.
-
Abdullah Al-Ani has nothing to disclose.
-
Dr. Popovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Popovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
-
Dr. Benard-Seguin has nothing to disclose.
-
Dr. Margolin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J.